Weight loss no longer has to be an exhausting uphill battle. Glucagon-like peptide-1 (GLP-1) drugs – sold under brand names such as Ozempic, Wegovy and Mounjaro – have revolutionised how we tackle obesity, delivering dramatic results through a simple injection.
Adults on the highest doses have been shown to lose
Little wonder these treatments are ferociously popular. In the US, approximatelyy they’ve tried GLP-1s – that’s 41 million people. Across the Atlantic, an estimated the UK took a weight-loss drug in the last year.
